Suppr超能文献

介入放射学会关于经皮射频消融治疗肝肿瘤的立场声明。

Society of Interventional Radiology position statement on percutaneous radiofrequency ablation for the treatment of liver tumors.

作者信息

Gervais Debra A, Goldberg S Nahum, Brown Daniel B, Soulen Michael C, Millward Steven F, Rajan Dheeraj K

机构信息

Department of Radiology, Division of Abdominal Imaging and Intervention, Massachusetts General Hospital, White 270, 55 Fruit St, Boston, MA 02114, USA.

出版信息

J Vasc Interv Radiol. 2009 Jul;20(7 Suppl):S342-7. doi: 10.1016/j.jvir.2009.04.029.

Abstract

Focal tumor ablation--whether applied percutanously, laparoscopically, or by means of open surgery--is an effective therapy for selected liver tumors. The choice of liver ablation as well as the choice between percutaneous and surgical approaches is dependent on tumor factors, patient factors, and other viable treatment options. Currently, the largest cumulative reported experience is with radiofrequency (RF) ablation of hepatocellular carcinoma and colorectal metastases. This document is a position statement of the Interventional Oncology Task Force and the Standards Division of the Society of Interventional Radiology regarding the use of percutaneous RF ablation for the treatment of liver tumors.

摘要

局部肿瘤消融——无论是经皮、腹腔镜还是通过开放手术进行——对于特定的肝脏肿瘤是一种有效的治疗方法。肝脏消融方式的选择以及经皮和手术方法之间的选择取决于肿瘤因素、患者因素和其他可行的治疗选择。目前,报告累积经验最多的是肝细胞癌和结直肠癌转移灶的射频(RF)消融。本文档是介入肿瘤学特别工作组和介入放射学会标准部关于使用经皮射频消融治疗肝脏肿瘤的立场声明。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验